These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22235058)

  • 1. Aluminum as an adjuvant in Crohn's disease induction.
    Lerner A
    Lupus; 2012 Feb; 21(2):231-8. PubMed ID: 22235058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis.
    Lerner A
    Ann N Y Acad Sci; 2007 Jun; 1107():329-45. PubMed ID: 17804561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in mucosal immunity leading to Crohn's disease.
    Cobrin GM; Abreu MT
    Immunol Rev; 2005 Aug; 206():277-95. PubMed ID: 16048555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Crohn's disease: a still tourbillon of etiopathogenetic theories and therapeutic strategies. Some implications in the field of urology].
    Alberti C
    G Chir; 2010 Mar; 31(3):124-33. PubMed ID: 20426926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral fat and gut inflammation.
    Drouet M; Dubuquoy L; Desreumaux P; Bertin B
    Nutrition; 2012 Feb; 28(2):113-7. PubMed ID: 22208553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Th1 immune pathway as a therapeutic target in Crohn's disease.
    Bamias G; Sugawara K; Pagnini C; Cominelli F
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1279-86. PubMed ID: 14758766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity in Crohn's disease: the reverse side of the medal.
    Dessein R; Chamaillard M; Danese S
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S144-7. PubMed ID: 18806708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response.
    Sato T; Nakai T; Tamura N; Okamoto S; Matsuoka K; Sakuraba A; Fukushima T; Uede T; Hibi T
    Gut; 2005 Sep; 54(9):1254-62. PubMed ID: 16099792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects.
    Perricone C; Colafrancesco S; Mazor RD; Soriano A; Agmon-Levin N; Shoenfeld Y
    J Autoimmun; 2013 Dec; 47():1-16. PubMed ID: 24238833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.
    Pizarro TT; Michie MH; Bentz M; Woraratanadharm J; Smith MF; Foley E; Moskaluk CA; Bickston SJ; Cominelli F
    J Immunol; 1999 Jun; 162(11):6829-35. PubMed ID: 10352304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease.
    Miura S; Tsuzuki Y; Hokari R; Ishii H
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1183-90. PubMed ID: 9918423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications.
    Balfour Sartor R
    J Clin Gastroenterol; 2007; 41 Suppl 1():S37-43. PubMed ID: 17438417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ intestinal mucosal lymphocytes in the pathogenesis of Crohn's disease.
    Watanabe M; Takaishi H; Hosoda Y; Ezaki T; Yajima T; Inoue N; Ueno Y; Iwao Y; Ishii H; Ishikawa H
    J Gastroenterol; 1995 Nov; 30 Suppl 8():73-5. PubMed ID: 8563896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.
    Plevy SE; Landers CJ; Prehn J; Carramanzana NM; Deem RL; Shealy D; Targan SR
    J Immunol; 1997 Dec; 159(12):6276-82. PubMed ID: 9550432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations.
    Tomljenovic L; Shaw CA
    Lupus; 2012 Feb; 21(2):223-30. PubMed ID: 22235057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen targeting to MHC class II-enriched late endosomes in colonic epithelial cells: trafficking of luminal antigens studied in vivo in Crohn's colitis patients.
    Büning J; Hundorfean G; Schmitz M; Zimmer KP; Strobel S; Gebert A; Ludwig D
    FASEB J; 2006 Feb; 20(2):359-61. PubMed ID: 16373401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.